JPY5,809.00
1.01% day before yesterday
Tokyo, Sep 06, 08:10 am CET
ISIN
JP3160400002
Symbol
4523
Index
Sector
Industry

Eisai Stock price

JPY5,809.00
+562.00 10.71% 1M
-283.00 4.65% 6M
-1,243.00 17.63% YTD
-3,274.00 36.05% 1Y
-3,411.00 37.00% 3Y
+521.00 9.85% 5Y
+1,555.50 36.57% 10Y
Tokyo, Closing price Fri, Sep 06 2024
-59.00 1.01%
ISIN
JP3160400002
Symbol
4523
Index
Sector
Industry

Key metrics

Market capitalization JPY1.66t
Enterprise Value JPY1.56t
P/E (TTM) P/E ratio 51.02
EV/FCF (TTM) EV/FCF 64.02
EV/Sales (TTM) EV/Sales 2.13
P/S ratio (TTM) P/S ratio 2.26
P/B ratio (TTM) P/B ratio 1.85
Dividend yield 2.75%
Last dividend (FY25) JPY160.00
Revenue growth (TTM) Revenue growth -3.07%
Revenue (TTM) Revenue JPY733.85b
EBIT (operating result TTM) EBIT JPY25.18b
Free Cash Flow (TTM) Free Cash Flow JPY24.40b
Cash position JPY303.94b
EPS (TTM) EPS JPY113.86
P/E forward 36.27
P/S forward 2.16
EV/Sales forward 2.03
Show more

Is Eisai a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Eisai Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a Eisai forecast:

7x Buy
44%
7x Hold
44%
2x Sell
13%

Analyst Opinions

16 Analysts have issued a Eisai forecast:

Buy
44%
Hold
44%
Sell
13%

Financial data from Eisai

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
733,845 733,845
3% 3%
100%
- Direct Costs 151,170 151,170
13% 13%
21%
582,675 582,675
0% 0%
79%
- Selling and Administrative Expenses 348,178 348,178
12% 12%
47%
- Research and Development Expense 169,610 169,610
3% 3%
23%
64,887 64,887
32% 32%
9%
- Depreciation and Amortization 39,704 39,704
1% 1%
5%
EBIT (Operating Income) EBIT 25,183 25,183
54% 54%
3%
Net Profit 32,648 32,648
33% 33%
4%

In millions JPY.

Don't miss a Thing! We will send you all news about Eisai directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs. The Other Business segment deals with food additives and chemicals. The company was founded by Toyoji Naito in November 1936 and is headquartered in Tokyo, Japan.

Head office Japan
CEO Haruo Naito
Employees 11,067
Founded 1936
Website www.eisai.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today